Showing 121 - 140 of 249 results
X-rays reveal the key to the effectiveness of new Alzheimer’s drugs
User Meeting 2020 Prizes & Awards
Awards and prizes granted at the User Meeting 2020 for scientists.
Radionuclides in medicine
Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs to diagnose or treat disease.
For three unknown medical radionuclides, students will graph their decay over time, use the graph to calculate their half-life, and determine the identify and use of each radionuclide using background information provided.
Scanners to go to a new home after a decade of excellence in preclinical imaging research
Following a decade of imaging to support research and clinical trials at ANSTO and the University of Sydney’s Brain and Mind Centre at Camperdown, two PET scanners have been transferred to the University of Wollongong.
Call for Proposals
Chronic kidney disease of unknown origin
In 2017, ANSTO's CEO signed a Memorandum of Understanding with Sri Lanka to work together to investigate the epidemiology of Chronic Kidney Disease of unknown origin (CKDu).
User Meeting 2020 Invited Speakers
The User Advisory Committee (UAC) are pleased to present this year's invited speakers.
ANSTO and the Powerhouse Museum: a powerful new partnership for the applied arts and sciences
ANSTO, the home of Australia’s nuclear science expertise and the Powerhouse Museum, home of Australia’s excellence and innovation in the applied arts and sciences will collaborate on research projects, establish an Indigenous Cultural Research Scholarship and combine efforts on STEM outreach activities.
Nuclear Medicine
ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.
Blueprint for future drugs
Structure of protein involved in immune response pair revealed.
Nanoprobe beamline (NANO) - under construction
The BRIGHT Nanoprobe beamline provides a unique facility capable of spectroscopic and full-field imaging. NANO will undertake high-resolution elemental mapping and ptychographic coherent diffraction imaging. Elemental mapping and XANES studies (after DCM upgrade) will be possible at sub-100 nm resolution, with structural features able to be studied down to 15 nm using ptychography.
Revealing the 'hidden half' of grain using imaging at ANSTO's Australian Synchrotron to benefit Australian agriculture
Professor of Soil Science at The University of Queensland, Peter Kopittke and partner investigator Prof Enzo Lombi of the University of SA are very optimistic about the use of a new synchrotron-based imaging technique that captures in 3D the complex interaction of soil and root.
Mo-99 Manufacturing Facility
ANSTO's Mo-99 manufacturing facility secures Australia’s ability to produce Mo-99 to meet current and future domestic demand and provide a significant proportion to support global demand.
Gamma radiation imaging technology
A new imaging technology developed at ANSTO makes it possible to image, identify and locate gamma-ray radiation in a safe and timely manner.
Exhibition recognised with prestigious MAGNA 2022 Research award
A Powerhouse exhibition was recognised with a prestigious Museums and Galleries National Award for Research at a ceremony in Perth this morning. The Invisible Revealed exhibition was organised in collaboration with ANSTO and the University of NSW.
DRAXIMAGE MACROSALB®
Update: Regional Cooperative Agreement (RCA) Cooperative Projects (Asia and Pacific)
ANSTO is coordinating and facilitating the calling of pre-concept papers for the next cycle of technical cooperative project proposals under the Regional Cooperative Agreement for Research, Development and Training Related to Nuclear Science and Technology for Asia and the Pacific (RCA) | IAEA
Supporting Australia’s resources sector manage Naturally Occurring Radioactive Materials
Fine-tuning chemistry for advanced materials
Doping with transition metals produced stability in bismuth oxide.